Characterising Oligos: Addressing Biopharma Challenges
Advanced LC-MS Analysis for Oligonucleotide Therapeutics
About This Webinar
The oligonucleotide therapeutics market is growing rapidly, driving the need for robust structural characterization to ensure safety and efficacy. LC-MS/MS enables detailed analysis of sequence, modifications, and impurities—but it comes with challenges. Analysts often struggle with isomer resolution, workflow automation, and streamlined reporting. This webinar is designed for LC-MS scientists facing these analytical “knots.” We’ll explore how software solutions like Byos help untangle complexity with automated, high-fidelity processing and reporting—supporting confident, high-throughput oligo analysis and critical quality assessments.
Key Takeaways:
By attending, you’ll learn how to:
- Confidently characterize mRNA sequences, modifications, and 5′ Cap structures using LC-MS/MS
- Detect and distinguish isomers and impurities with automated, high-fidelity processing
- Streamline data review with vendor-neutral analysis and customizable reports
- Simplify regulatory documentation with automated CQA reporting
Register Now